Cargando…

Conbercept for patients with age-related macular degeneration: a systematic review

BACKGROUND: Conbercept is a novel vascular endothelial growth factor (VEGF) inhibitor for the treatment of wet age-related macular degeneration (AMD). This systematic review aims to assess the efficacy and safety of conbercept in the treatment of wet AMD. METHODS: PubMed, Embase, Cochrane Library, C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jiaxing, Liang, Yi, Xie, Juan, Li, Dong, Hu, Qian, Li, Xiaosi, Zheng, Wenyi, He, Rui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003117/ https://www.ncbi.nlm.nih.gov/pubmed/29902977 http://dx.doi.org/10.1186/s12886-018-0807-1

Ejemplares similares

Profile of conbercept in the treatment of neovascular age-related macular degeneration
por: Lu, Xinmin, et al.
Publicado: (2015)

Cost-effectiveness of intravitreal conbercept versus other treatments for wet age-related macular degeneration
por: Chen, Rui, et al.
Publicado: (2020)

Clinical effectiveness of ranibizumab and conbercept for neovascular age-related macular degeneration: a meta-analysis
por: Wang, Luping, et al.
Publicado: (2018)

Ranibizumab and conbercept for treating wet age-related macular degeneration in China: A systematic review and meta-analysis
por: Pengfei, Jiang, et al.
Publicado: (2021)

Short-Term Results of Switch from Conbercept to Bevacizumab or Ranibizumab in Eyes with Persistent Neovascular Age-Related Macular Degeneration
por: Wang, Zongyi, et al.
Publicado: (2020)

Different conbercept injection strategies for the treatment of exudative age-related macular degeneration: A retrospective cohort study
por: Gao, Lei, et al.
Publicado: (2020)

Conbercept and Retinal Photocoagulation in the treatment of Diabetic Macular Edema
por: Meng, Weizhe, et al.
Publicado: (2019)

Metabolomics study of treatment response to conbercept of patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
por: Shen, Yinchen, et al.
Publicado: (2022)

Conbercept for Treatment of Neovascular Age-Related Macular Degeneration and Visual Impairment due to Diabetic Macular Edema or Pathologic Myopia Choroidal Neovascularization: A Systematic Review and Meta-Analysis
por: Zhou, Pengxiang, et al.
Publicado: (2021)

Eltrombopag versus romiplostim in treatment of adult patients with immune thrombocytopenia: A systematic review incorporating an indirect-comparison meta-analysis
por: Zhang, Jiaxing, et al.
Publicado: (2018)

Eltrombopag versus romiplostim in treatment of children with persistent or chronic immune thrombocytopenia: a systematic review incorporating an indirect-comparison meta-analysis
por: Zhang, Jiaxing, et al.
Publicado: (2018)

Evaluation of a clinical pharmacist consultation service for patients with infectious diseases in China: a systematic review and meta-analysis
por: Zhang, Jiaxing, et al.
Publicado: (2020)

Clinical observations on the use of new anti-VEGF drug, conbercept, in age-related macular degeneration therapy: a meta-analysis
por: Cui, Chunmei, et al.
Publicado: (2017)

The efficacy and safety of aflibercept and conbercept in diabetic macular edema
por: Cai, Siwei, et al.
Publicado: (2018)

One-Year Effectiveness Study of Intravitreously Administered Conbercept(®) Monotherapy in Diabetic Macular Degeneration: A Systematic Review and Meta-Analysis
por: Wang, Heping, et al.
Publicado: (2020)

Cost-Effectiveness of Conbercept vs. Ranibizumab for Age-Related Macular Degeneration, Diabetic Macular Edema, and Pathological Myopia: Population-Based Cohort Study and Markov Model
por: Cui, Zhuang, et al.
Publicado: (2021)

Clinical outcomes of 1 + PRN and 3 + Q3M regimens of intravitreal conbercept injection for exudative age-related macular degeneration
por: Gao, Lei, et al.
Publicado: (2020)

Spectral-domain optical coherence tomography combined with electroretinography in the assessment of conbercept for neovascular age-related macular degeneration: a preliminary study
por: Wang, Xing, et al.
Publicado: (2023)

Standard-Dose Proton Pump Inhibitors in the Initial Non-eradication Treatment of Duodenal Ulcer: Systematic Review, Network Meta-Analysis, and Cost-Effectiveness Analysis
por: Zhang, Jiaxing, et al.
Publicado: (2019)

Analysis on short-term change of macular function and the correlates after intravitreal conbercept for CRVO-ME
por: Wang, Yun-Chang, et al.
Publicado: (2022)

Clinical effect of conbercept on improving diabetic macular ischemia by OCT angiography
por: Zhu, Ziyi, et al.
Publicado: (2020)

Evaluation of the efficacy of Conbercept in the treatment of diabetic macular edema based on OCTA
por: Ba, Teer, et al.
Publicado: (2020)

Comparison of effectiveness and safety between conbercept and ranibizumab for treatment of neovascular age-related macular degeneration. A retrospective case-controlled non-inferiority multiple center study
por: Cui, J, et al.
Publicado: (2018)

Assessment of conbercept therapy for high myopia macular neovascularization by optical coherence tomography angiography
por: Cheng, Lu-Na, et al.
Publicado: (2020)

Effect of Conbercept Treatment on Macular Edema and Microvascular Structure in Eyes with Retinal Vein Occlusions
por: Ding, Xiaoxia, et al.
Publicado: (2022)

Conbercept improves macular microcirculation and retinal blood supply in the treatment of nonischemic branch retinal vein occlusion macular edema
por: Huang, Yikeng, et al.
Publicado: (2022)

Full-Thickness Macular Hole After Intravitreal Conbercept Injection in Branch Retinal Vein Occlusion
por: Xie, Pinxue, et al.
Publicado: (2023)

Nanotechnology for Age-Related Macular Degeneration
por: Yang, Bo, et al.
Publicado: (2021)

Cytokine and Chemokine Profile Changes in Patients After Intravitreal Conbercept Injection for Diabetic Macular Edema
por: Wei, Qingquan, et al.
Publicado: (2019)

Switching to Conbercept in Diabetic Macular Edema After Unsatisfactory Response to Previous Intravitreal Injection of Ranibizumab
por: Xing, Peiyu, et al.
Publicado: (2023)

Clinical Observation of Phacoemulsification Combined with Intravitreal Injection of Conbercept in Cataract Patients with Diabetic Macular Edema
por: Wang, Jing, et al.
Publicado: (2021)

Today and Future of Age-Related Macular Degeneration
por: Liu, Kang, et al.
Publicado: (2012)

Age-related macular degeneration.
por: McConnell, V., et al.
Publicado: (2005)

Age-related macular degeneration
por: Querques, Giuseppe, et al.
Publicado: (2011)

Age-related macular degeneration
por: Mathenge, Wanjiku
Publicado: (2014)

Wnt signaling in age-related macular degeneration: human macular tissue and mouse model
por: Tuo, Jingsheng, et al.
Publicado: (2015)

Short-term effect of intravitreal conbercept injection on major and macular branch retinal vein occlusion
por: Tao, Yuan, et al.
Publicado: (2019)

Evaluation of short-term intraocular pressure changes after intravitreal injection of Conbercept in patients with diabetic macular edema
por: Hu, Yunyan, et al.
Publicado: (2022)

Intravitreal Conbercept with Grid/Focal Photocoagulation for the Treatment of Diabetic Macular Edema: A Systematic Review and Meta-Analysis
por: Sun, Xiaoyan, et al.
Publicado: (2022)

Screening for biomarkers in age-related macular degeneration
por: Han, Daoxin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rol8dpjcq26invc17tffd57i86